AEROVATE THERAPEUTICS

Aerovate Therapeutics is a biotechnology company focused on developing drugs that meaningfully improve the lives of patients with rare cardiopulmonary disease. Aerovate's program is a potentially disease-modifying drug, AV-101, for people who suffer from pulmonary arterial hypertension (PAH). AV-101 is a proprietary inhaled dry powder formulation of the drug imatinib that delivers this medicine directly to diseased lung tissues while reducing systemic adverse side effects. The company was founded and incubated by RA Capital Management, a multi-stage investment manager focused on healthcare and life sciences.

#SimilarOrganizations #People #Financial #Website #More

AEROVATE THERAPEUTICS

Social Links:

Linkedin

X

Industry:

Biotechnology Life Science Medical

Founded:

2019-01-01

Address:

Boston, Massachusetts, United States

Country:

United States

Website Url:

http://www.aerovatetx.com

Total Employee:

11+

Status:

Active

Contact:

+1 617 778 2494

Email Addresses:

[email protected]

Total Funding:

72.6 M USD

Technology used in webpage:

Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Wordpress Plugins

Similar Organizations

atalanta-therapeutics-logo

Atalanta Therapeutics

Atalanta Therapeutics is a biotechnology company pioneering new treatment options for neurodegenerative diseases.

novellus-logo

Novellus

Novellus is a biotechnology company working to develop engineered cellular medicines.

orig3n-logo

ORIG3N

ORIG3N is a biotechnology company developing breakthrough treatments for rare genetically inherited diseases.

Current Advisors List

maha-katabi_image

Maha Katabi Board Member @ Aerovate Therapeutics
Board_member
2020-08-06

joshua-resnick_image

Joshua Resnick Board Member @ Aerovate Therapeutics
Board_member
2020-08-06

Current Employees Featured

hunter-gillies_image

Hunter Gillies
Hunter Gillies CMO @ Aerovate Therapeutics
CMO

benjamin-t-dake_image

Benjamin T Dake
Benjamin T Dake President & Founder @ Aerovate Therapeutics
President & Founder
2019-01-01

ralph-niven_image

Ralph Niven
Ralph Niven CDO @ Aerovate Therapeutics
CDO

george-eldridge_image

George Eldridge
George Eldridge Chief Financial Officer @ Aerovate Therapeutics
Chief Financial Officer
2021-03-01

timothy-p-noyes_image

Timothy P. Noyes
Timothy P. Noyes Chief Executive Officer @ Aerovate Therapeutics
Chief Executive Officer
2021-02-01

Founder

benjamin-t-dake_image

Benjamin T Dake

Stock Details

Company's stock symbol is NASDAQ:AVTE

Investors List

surveyor-capital_image

Surveyor Capital

Surveyor Capital investment in Series A - Aerovate Therapeutics

atlas-venture_image

Atlas Venture

Atlas Venture investment in Series A - Aerovate Therapeutics

cormorant-asset-management_image

Cormorant Asset Management

Cormorant Asset Management investment in Series A - Aerovate Therapeutics

sofinnova-ventures_image

Sofinnova Investments

Sofinnova Investments investment in Series A - Aerovate Therapeutics

osage-university-partners_image

OUP (Osage University Partners)

OUP (Osage University Partners) investment in Series A - Aerovate Therapeutics

ra-capital-management_image

RA Capital Management

RA Capital Management investment in Seed Round - Aerovate Therapeutics

Official Site Inspections

http://www.aerovatetx.com Semrush global rank: 3.03 M Semrush visits lastest month: 5.34 K

Host Informations
Whois Informations

Loading ...

More informations about "Aerovate Therapeutics" on Search Engine